MGMT and neoplasm: The efficacy of this chemotherapeutic protocol depends on the methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter, where high methylation levels are associated with increased tumor cell sensitivity to radio- and chemo-induced mutagenesis [4].